Kansas City Life Insurance Company (KCLI)
OTCMKTS · Delayed Price · Currency is USD
36.25
-0.25 (-0.68%)
Aug 13, 2025, 10:29 AM EDT
Oncternal Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Investments in Debt Securities | 2,346 | 2,348 | 2,350 | 2,200 | 3,082 | 3,116 | Upgrade |
Investments in Equity & Preferred Securities | 3.03 | 3.24 | 3.25 | 7.14 | 9.72 | 9.85 | Upgrade |
Policy Loans | 86.11 | 84.91 | 84.03 | 82.74 | 82.06 | 84.45 | Upgrade |
Other Investments | 120.56 | 113.74 | 119.06 | 77.25 | 87.34 | 129.95 | Upgrade |
Total Investments | 3,218 | 3,221 | 3,246 | 3,100 | 4,000 | 4,107 | Upgrade |
Cash & Equivalents | 7.87 | 8.1 | 9.7 | 7.77 | 5.42 | 7.2 | Upgrade |
Reinsurance Recoverable | 766.27 | 781.67 | 828.66 | 886.73 | 399.95 | 391.44 | Upgrade |
Other Receivables | 32.66 | 33.05 | 31.48 | 29.15 | 30.3 | 31.41 | Upgrade |
Deferred Policy Acquisition Cost | 291.49 | 302.13 | 308.74 | 327.54 | 292.03 | 276.43 | Upgrade |
Separate Account Assets | 411.89 | 413.43 | 395.95 | 381.58 | 504.98 | 463.04 | Upgrade |
Property, Plant & Equipment | - | 13.47 | 13.28 | 14.01 | 16.35 | 19.38 | Upgrade |
Goodwill | - | 42.3 | 42.3 | 42.3 | 42.3 | 42.3 | Upgrade |
Other Intangible Assets | - | 16.1 | 16.9 | 17.7 | 18.4 | 19.2 | Upgrade |
Other Long-Term Assets | 261.35 | 187.27 | 159.82 | 158.06 | 124.12 | 105.57 | Upgrade |
Total Assets | 4,990 | 5,019 | 5,053 | 4,965 | 5,433 | 5,463 | Upgrade |
Insurance & Annuity Liabilities | 3,758 | 3,778 | 3,807 | 3,875 | 3,830 | 3,790 | Upgrade |
Unpaid Claims | 57.7 | 56.23 | 59.3 | 56.98 | 69.79 | 71.34 | Upgrade |
Separate Account Liability | 411.89 | 413.43 | 395.95 | 381.58 | 504.98 | 463.04 | Upgrade |
Other Long-Term Liabilities | 179.03 | 189.48 | 181.26 | 160.27 | 198.02 | 229.44 | Upgrade |
Total Liabilities | 4,407 | 4,438 | 4,444 | 4,473 | 4,603 | 4,554 | Upgrade |
Common Stock | 23.12 | 23.12 | 23.12 | 23.12 | 23.12 | 23.12 | Upgrade |
Additional Paid-In Capital | 41.03 | 41.03 | 41.03 | 41.03 | 41.03 | 41.03 | Upgrade |
Retained Earnings | 920.08 | 948.99 | 959.37 | 910.44 | 933.34 | 933.09 | Upgrade |
Treasury Stock | -241.3 | -241.3 | -241.3 | -241.3 | -241.3 | -241.3 | Upgrade |
Comprehensive Income & Other | -160.33 | -190.38 | -172.86 | -241.59 | 74.25 | 152.8 | Upgrade |
Shareholders' Equity | 582.6 | 581.45 | 609.36 | 491.69 | 830.43 | 908.74 | Upgrade |
Total Liabilities & Equity | 4,990 | 5,019 | 5,053 | 4,965 | 5,433 | 5,463 | Upgrade |
Filing Date Shares Outstanding | 9.68 | 9.68 | 9.68 | 9.68 | 9.68 | 9.68 | Upgrade |
Total Common Shares Outstanding | 9.68 | 9.68 | 9.68 | 9.68 | 9.68 | 9.68 | Upgrade |
Net Cash (Debt) | 7.87 | 8.1 | 9.7 | 7.77 | 5.42 | 7.2 | Upgrade |
Net Cash Growth | 7.78% | -16.44% | 24.81% | 43.35% | -24.77% | -49.40% | Upgrade |
Net Cash Per Share | 0.81 | 0.84 | 1.00 | 0.80 | 0.56 | 0.74 | Upgrade |
Book Value Per Share | 60.16 | 60.05 | 62.93 | 50.78 | 85.76 | 93.84 | Upgrade |
Tangible Book Value | 582.6 | 523.05 | 550.16 | 431.69 | 769.73 | 847.24 | Upgrade |
Tangible Book Value Per Share | 60.16 | 54.01 | 56.81 | 44.58 | 79.49 | 87.49 | Upgrade |
Land | - | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | Upgrade |
Buildings | - | 23.42 | 22.31 | 21.82 | 21.8 | 21.59 | Upgrade |
Machinery | - | 33.23 | 33.07 | 36.8 | 36.31 | 35.96 | Upgrade |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.